In cancers where HR repair is impaired, such as those harboring mutations in BRCA1 and BRCA2 genes, cancer cells heavily rely on alternative DNA repair mechanisms, such as base excision repair (BER), to counteract DNA damage. This evidence concerns the gene BRCA2 and cancer.